Mismatch repair deficiency in ovarian cancer. Read more about Mismatch repair deficiency in ovarian cancer.
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care. Read more about Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care.
Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited setting. Read more about Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited setting.
Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer. Read more about Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer.
Differentiating complete hydatidiform mole and coexistent fetus and placental mesenchymal dysplasia: A series of 9 cases and review of the literature. Read more about Differentiating complete hydatidiform mole and coexistent fetus and placental mesenchymal dysplasia: A series of 9 cases and review of the literature.
Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer. Read more about Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer.
Obese endometrial cancer survivors' perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions. Read more about Obese endometrial cancer survivors' perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions.
The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer. Read more about The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer.
Detection of a somatic GREB1-NCOA1 gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT). Read more about Detection of a somatic GREB1-NCOA1 gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT).
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? Read more about Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
